1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pet Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Pet Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Attenuated Live Vaccines
1.4.3 Conjugate Vaccines
1.4.4 Inactivated Vaccines
1.4.5 Subunit Vaccines
1.4.6 Toxoid Vaccines
1.4.7 DNA Vaccines
1.4.8 Recombinant Vaccines
1.5 Market by Application
1.5.1 Global Pet Vaccine Market Share by Application: 2021-2026
1.5.2 Canine
1.5.3 Avian
1.5.4 Feline
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pet Vaccine Market
1.8.1 Global Pet Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pet Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Pet Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pet Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pet Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Pet Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Pet Vaccine Sales Volume
3.3.1 North America Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Pet Vaccine Sales Volume
3.4.1 East Asia Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Pet Vaccine Sales Volume (2015-2020)
3.5.1 Europe Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Pet Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Pet Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Pet Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Pet Vaccine Sales Volume (2015-2020)
3.9.1 Africa Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Pet Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Pet Vaccine Sales Volume (2015-2020)
3.11.1 South America Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Pet Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Pet Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Pet Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Pet Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pet Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pet Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pet Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pet Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pet Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pet Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pet Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pet Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pet Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pet Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Pet Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Pet Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Pet Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Pet Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Pet Vaccine Business
16.1 Bayer Healthcare
16.1.1 Bayer Healthcare Company Profile
16.1.2 Bayer Healthcare Pet Vaccine Product Specification
16.1.3 Bayer Healthcare Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Merial (Sanofi)
16.2.1 Merial (Sanofi) Company Profile
16.2.2 Merial (Sanofi) Pet Vaccine Product Specification
16.2.3 Merial (Sanofi) Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Ceva
16.3.1 Ceva Company Profile
16.3.2 Ceva Pet Vaccine Product Specification
16.3.3 Ceva Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Vetoquinol S.A
16.4.1 Vetoquinol S.A Company Profile
16.4.2 Vetoquinol S.A Pet Vaccine Product Specification
16.4.3 Vetoquinol S.A Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Merck Animal Health
16.5.1 Merck Animal Health Company Profile
16.5.2 Merck Animal Health Pet Vaccine Product Specification
16.5.3 Merck Animal Health Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Boehringer Ingelheim
16.6.1 Boehringer Ingelheim Company Profile
16.6.2 Boehringer Ingelheim Pet Vaccine Product Specification
16.6.3 Boehringer Ingelheim Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Zoetis (Pfizer)
16.7.1 Zoetis (Pfizer) Company Profile
16.7.2 Zoetis (Pfizer) Pet Vaccine Product Specification
16.7.3 Zoetis (Pfizer) Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Heska Co.
16.8.1 Heska Co. Company Profile
16.8.2 Heska Co. Pet Vaccine Product Specification
16.8.3 Heska Co. Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Eli Lilly
16.9.1 Eli Lilly Company Profile
16.9.2 Eli Lilly Pet Vaccine Product Specification
16.9.3 Eli Lilly Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Virbac
16.10.1 Virbac Company Profile
16.10.2 Virbac Pet Vaccine Product Specification
16.10.3 Virbac Pet Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Pet Vaccine Manufacturing Cost Analysis
17.1 Pet Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pet Vaccine
17.4 Pet Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pet Vaccine Distributors List
18.3 Pet Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pet Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Pet Vaccine (2021-2026)
20.3 Global Forecasted Price of Pet Vaccine (2015-2026)
20.4 Global Forecasted Production of Pet Vaccine by Region (2021-2026)
20.4.1 North America Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Pet Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Pet Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Pet Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pet Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Pet Vaccine by Country
21.3 Europe Market Forecasted Consumption of Pet Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Pet Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Pet Vaccine by Country
21.6 Middle East Forecasted Consumption of Pet Vaccine by Country
21.7 Africa Forecasted Consumption of Pet Vaccine by Country
21.8 Oceania Forecasted Consumption of Pet Vaccine by Country
21.9 South America Forecasted Consumption of Pet Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Pet Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer